Nitric Oxide Inhibition of Rickettsia rickettsii

Infect Immun. 2021 Nov 16;89(12):e0037121. doi: 10.1128/IAI.00371-21. Epub 2021 Sep 7.

Abstract

Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever, is an enzootic, obligate, intracellular bacterial pathogen. Nitric oxide (NO) synthesized by the inducible NO synthase (iNOS) is a potent antimicrobial component of innate immunity and has been implicated in the control of virulent Rickettsia spp. in diverse cell types. In this study, we examined the antibacterial role of NO on R. rickettsii. Our results indicate that NO challenge dramatically reduces R. rickettsii adhesion through the disruption of bacterial energetics. Additionally, NO-treated R. rickettsii cells were unable to synthesize protein or replicate in permissive cells. Activated, NO-producing macrophages restricted R. rickettsii infections, but inhibition of iNOS ablated the inhibition of bacterial growth. These data indicate that NO is a potent antirickettsial effector of innate immunity that targets energy generation in these pathogenic bacteria to prevent growth and subversion of infected host cells.

Keywords: Rickettsia; host defense; innate immunity; nitric oxide.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Energy Metabolism
  • Host-Pathogen Interactions* / immunology
  • Immunity, Innate
  • Macrophages / immunology
  • Macrophages / metabolism
  • Macrophages / microbiology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / metabolism
  • Rickettsia rickettsii / physiology*
  • Rocky Mountain Spotted Fever / immunology
  • Rocky Mountain Spotted Fever / metabolism*
  • Rocky Mountain Spotted Fever / microbiology*

Substances

  • Nitric Oxide
  • Nitric Oxide Synthase Type II